ReviewAmerican journal of translational research2025
Effectiveness of ginger supplementation in alleviating hyperemesis gravidarum: a systematic review and meta-analysis.
Review in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nausea and vomiting affect 50-80% of pregnant women, with a subset developing hyperemesis gravidarum (HG), a severe condition leading to weight loss and malnutrition. Given that over 28% of pregnant women globally seek herbal alternatives due to concerns about the safety of prescription medications, ginger has emerged as a popular remedy for such symptoms. This meta-analysis systematically evaluates the efficacy of ginger supplementation in managing HG based on clinical studies. Following PRISMA guidelines, a comprehensive search was conducted across PubMed, Cochrane, Scopus, ScienceDirect, and ResearchGate. Ten high-quality randomized controlled trials and comparative studies were included from a pool of 32 identified papers, based on strict eligibility criteria. These trials examined various forms of ginger supplementation (capsules, powders, biscuits) and compared them to controls such as placebos, vitamin B6, and metoclopramide. A pooled odds ratio of 0.41 (95% CI: 0.22-0.79, P = 0.008) indicated a significant reduction in nausea and vomiting symptoms. Ginger supplementation was well-tolerated with minimal side effects and no significant harm to maternal or fetal health. This analysis supports the inclusion of ginger as a safe, flexible, and effective non-pharmacologic treatment for HG symptoms in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.